Fortress Wealth Group, LLC Gilead Sciences, Inc. Transaction History

Fortress Wealth Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$76.01 - $86.7 $608 - $693	8 Added 0.24%	3,308 $254,000
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $32,160 - $36,641	-416 Reduced 11.19%	3,300 $273,000
Q4 2022 Feb 07, 2023	BUY	$62.32 - $89.47 $997 - $1,431	16 Added 0.43%	3,716 $319,000
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $220,298 - $251,637	3,700 New	3,700 $228,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Fortress Wealth Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Fortress Wealth Group, LLC with notifications on news.